Lidocaine Hydrochloride Hameln Pharma (Lidocaine Hydrochloride)

Lidocaine blocks voltage‑gated sodium channels on nerve membranes, preventing sodium influx that is essential for depolarization. This reversible blockade stops the transmission of nerve impulses, resulting in loss of sensation in the area where the drug is administered.

The dose of lidocaine Hydrochloride is determined by the prescribing clinician based on the specific procedure, route of administration, patient weight, and clinical condition. Only a qualified health professional should set the appropriate dosing regimen.

Safety data for lidocaine in pregnancy and lactation are limited. The drug should only be used when the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified health professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Lidocaine is an amide‑type local anesthetic with a rapid onset and moderate duration, making it suitable for many procedures. Compared with ester‑type agents like procaine, lidocaine has a lower risk of allergic reactions and a longer half‑life, while agents such as bupivacaine provide a longer duration but have a higher cardiotoxic potential.

Lidocaine Hydrochloride should be stored at room temperature, below 25 °C, in its original packaging. Protect the solution from direct light and moisture, and keep it out of reach of children. Do not freeze the product.

Lidocaine Hydrochloride is administered by a qualified health professional via injection. It can be given epidurally, intramuscularly, intravenously, or as part of an intravenous regional block, depending on the clinical indication and required depth of anesthesia.

Serious risks include seizures, severe cardiac arrhythmias, anaphylactic reactions, and methemoglobinemia. These events are rare but require immediate medical attention. Monitoring of cardiovascular and neurological status is essential during and after administration.

Patients with a known hypersensitivity to amide‑type local anesthetics, severe heart block, uncontrolled epilepsy, or those taking certain antiarrhythmic drugs that increase cardiotoxicity should avoid lidocaine unless a risk‑benefit assessment justifies its use.